Evidence map›Paper›PMID 42514955›Full record

ArticlePharmaceutics2026

Fusion Inhibition of Zika Virus Entry by a Teicoplanin Pseudoaglycone Derivative with Broad Antiviral Activity.

Zoltán Kopasz, Ilona Bereczki, Krisztina Leiner, Henrietta Papp, Eszter Boglárka Lőrincz, Levente Sipos-Szabó, Kornélia Bodó, Eszter Szabó, Mónika Madai, Brigitta Zana and 8 more

Abstract read
In one paragraph

Article in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Zoltán KopaszNational Laboratory of Virology, Szentágothai Research Centre, University of Pécs, Ifjúság útja 20, 7624 Pecs, Hungary.ORCID 0009-0006-1176-5529
Ilona BereczkiNational Laboratory of Virology, Szentágothai Research Centre, University of Pécs, Ifjúság útja 20, 7624 Pecs, Hungary.ORCID 0000-0003-4601-7257
Krisztina LeinerNational Laboratory of Virology, Szentágothai Research Centre, University of Pécs, Ifjúság útja 20, 7624 Pecs, Hungary.
Henrietta PappNational Laboratory of Virology, Szentágothai Research Centre, University of Pécs, Ifjúság útja 20, 7624 Pecs, Hungary.ORCID 0000-0003-3887-5657
Eszter Boglárka LőrinczDepartment of Pharmaceutical Chemistry, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.ORCID 0000-0003-1407-8960
Levente Sipos-SzabóDepartment of Organic Chemistry and Technology, Budapest University of Technology and Economics, 1111 Budapest, Hungary.
Kornélia BodóNational Laboratory of Virology, Szentágothai Research Centre, University of Pécs, Ifjúság útja 20, 7624 Pecs, Hungary.ORCID 0000-0001-9429-4377
Eszter SzabóNational Laboratory of Virology, Szentágothai Research Centre, University of Pécs, Ifjúság útja 20, 7624 Pecs, Hungary.
Mónika MadaiNational Laboratory of Virology, Szentágothai Research Centre, University of Pécs, Ifjúság útja 20, 7624 Pecs, Hungary.
Brigitta ZanaNational Laboratory of Virology, Szentágothai Research Centre, University of Pécs, Ifjúság útja 20, 7624 Pecs, Hungary.
Réka ErdeiDepartment of Organic Chemistry, University of Debrecen, H-4032 Debrecen, Hungary.
Gyula BattaDepartment of Organic Chemistry, University of Debrecen, H-4032 Debrecen, Hungary.ORCID 0000-0002-0442-1828
Tamás Kovács-ÖllerFaculty of Sciences, Institute of Biology, University of Pécs, Ifjúság útja 6, H-7624 Pecs, Hungary.ORCID 0000-0002-3353-4485
Zoltán VargaBiological Nanochemistry Research Group, Institute of Materials and Environmental Chemistry, HUN-REN Research Centre for Natural Sciences, Magyar Tudósok Körútja 2, H-1117 Budapest, Hungary.ORCID 0000-0002-5741-2669
Dávid BajuszMedicinal Chemistry Research Group and Drug Innovation Centre, HUN-REN Research Centre for Natural Sciences, Magyar Tudósok krt. 2, H-1117 Budapest, Hungary.ORCID 0000-0003-4277-9481
Gábor KemenesiNational Laboratory of Virology, Szentágothai Research Centre, University of Pécs, Ifjúság útja 20, 7624 Pecs, Hungary.ORCID 0000-0001-9775-3065
Anikó BorbásNational Laboratory of Virology, Szentágothai Research Centre, University of Pécs, Ifjúság útja 20, 7624 Pecs, Hungary.ORCID 0000-0001-8462-4547
Anett KuczmogNational Laboratory of Virology, Szentágothai Research Centre, University of Pécs, Ifjúság útja 20, 7624 Pecs, Hungary.

Funding

Hungarian Academy of Sciences János Bolyai Research ScholarsNational Research, Development and Innovation Office FK 142315National Research, Development and Innovation Office FK146063National Research, Development and Innovation Office HU-RIZONT-2025-00115National Research, Development and Innovation Office NKFI-1, ADVANCED_25, 152435National Research, Development and Innovation Office ÚNKP-23-3-I-PTE-1837University of Pecs 003_2025_PTE_RK/9University of Pecs 008_2025_PTE_RK/37
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

broad-spectrum antiviralchikungunya virusfusion inhibitorglycopeptide antibioticso’nyong-nyong virussevere acute respiratory syndrome coronavirus 2

Identifiers

PMID42514955
PMCPMC13415800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.